By Natalie Huet and Noëlle Mennella PARIS (Reuters) - Sanofi's board ousted its chief executive of six years at a special meeting on Wednesday, two days after it emerged he had fallen out with the French drugmaker's chairman, wiping more billions off its market value. The board said Sanofi would continue the strategy of international expansion pursued under Chris Viehbacher, blaming his dismissal on poor relations between the CEO and the board. But investors fear Sanofi may become more insular. "Viehbacher tried hard to change the DNA of the company but the board won in the end. ...
via Health News Headlines - Yahoo News http://ift.tt/1xDuLd2
No comments:
Post a Comment